IL31RA and breast cancer: This finding might be promising in using these biomarkers as a targeted therapy in treating BC in Egyptian patients by causing Knockdown of ROC-1 by siRNA silencing which induce CRL inactivation that cause accumulation of some special CRL substrates such as P21 causing arrested bladder cancer cells at G2 phase [58].